How has Genmab A/S EBITDA changed compared to the previous year?

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genmab A/S changed from 1.07 B USD to 1.32 B USD, representing a 23.34% change. The value is higher than the previous year.

What is the Genmab A/S EBITDA?

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

How is the Genmab A/S calculated?

EBITDA = EBIT + Depreciation & Amortization

How does Genmab A/S EBITDA affect the stock price?

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Genmab A/S historically and in real time.

Genmab A/S EBITDA

GMAB.CO

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genmab A/S (GMAB.CO) as of Jul 20, 2026 is 1.32 B USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.07 B USD — a change of 23.34% (higher).

Get this data via API

Financial Data API

EBITDA

1.32 BUSD

YoY

23.34%

Last updated: Jul 20, 2026

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genmab A/S is 2026 1.32 B USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genmab A/S was 2025 1.07 B USD. It decreases by 23.34% higher compared to the previous year.

Access this data via the Eulerpool API

Docs Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genmab A/S is 1.32 B USD in 2026.

Access this data via the Eulerpool API

Docs Get Free API Key

Income Statement — Genmab A/S

Revenue Gross Profit EBIT EBITDA Net Income EPS Cost of Goods Sold R&D Expenses SG&A Expenses Operating Expenses Interest Expense Pretax Income Tax Expense Depreciation & Amortization Revenue per Share EBIT per Share Diluted EPS EBITDA per Share Other Income/Expense

Genmab A/S EBITDA

Genmab A/S Stock analysis

Frequently Asked Questions about Genmab A/S stock

What is the Genmab A/S EBITDA 2026?

How has Genmab A/S EBITDA changed compared to the previous year?

How has Genmab A/S EBITDA developed historically?

What is the Genmab A/S EBITDA?

How is the Genmab A/S calculated?

How does Genmab A/S EBITDA affect the stock price?

Income Statement — Genmab A/S

All Key Metrics — Genmab A/S

Valuation

Income Statement

Margins

Balance Sheet

Cash Flow

Profitability

Leverage

Growth

Dividend

Workforce

Quality

Other